UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | K | L | M | O | P | R | S | T | U | V | W | Z
Number of items: 57.


Anilkumar, N; Parsons, M; Monk, R; Ng, T; Adams, JC; (2003) Interaction of fascin and protein kinase C alpha: a novel intersection in cell adhesion and motility. EMBO JOURNAL , 22 (20) pp. 5390-5402. 10.1093/emboj/cdg521.

Ardeshna, KM; Smith, P; Norton, A; Hancock, BW; Hoskin, PJ; MacLennan, KA; Marcus, RE; (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. LANCET , 362 (9383) 516 - 522.

Arkenau, HT; Bermann, A; Rettig, K; Strohmeyer, G; Porschen, R; Arbeitsgemeinschaft Gastrointestinale Onkologie, ; (2003) 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol , 14 (3) pp. 395-399.

Arkenau, HT; Kruse, F; Jend, HH; Porschen, R; (2003) [Differential diagnosis of morbus Crohn disease: intussusception of the colon]. Z Gastroenterol , 41 (7) pp. 663-666. 10.1055/s-2003-40549.

Atalay, G; Biganzoli, L; Renard, F; Paridaens, R; Cufer, T; Coleman, R; Calvert, AH; (2003) Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. EUR J CANCER , 39 (17) 2439 - 2449. 10.1016/S0959-8049(03)00601-4.


Balk, J; Chew, SK; Leaver, CJ; McCabe, PF; (2003) The intermembrane space of plant mitochondria contains a DNase activity that may be involved in programmed cell death. PLANT JOURNAL , 34 (5) pp. 573-583. 10.1046/j.1365-313X.2003.01748.x.

Bergamaschi, D; Gasco, M; Hiller, L; Sullivan, A; Syed, N; Trigiante, G; Yulug, I; (2003) p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell , 3 (4) pp. 387-402.

Birtle, AJ; Freeman, A; Masters, JRW; Payne, HA; Harland, SJ; (2003) Clinical Features of Patients Who Present with Metastatic Prostate Carcinoma and Serum Prostate-Specific Antigen (PSA) Levels < 10 ng/mL: The "PSA Negative" Patients. Cancer , 98 (11) pp. 2362-2367. 10.1002/cncr.11821.

Brada, M; Viviers, L; Abson, C; Hines, F; Britton, J; Ashley, S; Sardell, S; (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol , 14 (12) pp. 1715-1721.

Burcombe, RJ; Makris, A; Pittam, M; Finer, N; (2003) Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast , 12 (4) pp. 290-293.


Calabrese, CR; Batey, MA; Thomas, HD; Durkacz, BW; Wang, LZ; Kyle, S; Skalitzky, D; (2003) Identification of potent nontoxic poly(ADP-ribose) polymerase-1 inhibitors: Chemopotentiation and pharmacological studies. CLIN CANCER RES , 9 (7) 2711 - 2718.

Calvert, H; (2003) Pemetrexed (Alimta): A promising new agent for the treatment of breast cancer. SEMINARS IN ONCOLOGY , 30 (2) 2 - 5. 10.1053/sonc.2003.37267.


Dittrich, C; Dumez, H; Calvert, H; Hanauske, A; Faber, M; Wanders, J; Yule, M; (2003) Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumors. CLIN CANCER RES , 9 (14) 5195 - 5204.

de Bruin, EC; Meersma, D; de Wilde, J; den Otter, I; Schipper, EM; Medema, JP; Peltenburg, LT; (2003) A serine protease is involved in the initiation of DNA damage-induced apoptosis. Cell Death Differ , 10 (10) pp. 1204-1212. 10.1038/sj.cdd.4401296.


Flynn, AA; Pedley, RB; Green, AJ; Dearling, JL; El-Emir, E; Boxer, GM; Boden, R; (2003) The nonuniformity of antibody distribution in the kidney and its influence on dosimetry. Radiat Res , 159 (2) pp. 182-189.


Gaffan, J; Holden, L; Newlands, ES; Short, D; Fuller, S; Begent, RHJ; Rustin, GJS; (2003) Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study. BRIT J CANCER , 89 (10) 1849 - 1854. 10.1038/sj.bjc.6601383.


Hammond, KL; Loynes, HE; Folarin, AA; Smith, J; Whitfield, TT; (2003) Hedgehog signalling is required for correct anteroposterior patterning of the zebrafish otic vesicle. DEVELOPMENT , 130 (7) 1403 - 1417. 10.1242/dev.00360.


Kauppila, S; Maaty, WS; Chen, P; Tomar, RS; Eby, MT; Chapo, J; Chew, S; (2003) Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila. Oncogene , 22 (31) pp. 4860-4867. 10.1038/sj.onc.1206715.

Kostoula, V; Khan, K; Savage, K; Hochhauser, D; Stubbs, M; McStay, M; Dhillon, AP; (2003) Expression of c-kit (cd117) in neuroendocrine tumours - a target for therapy? ENDOCR-RELAT CANCER , 10 (4) 508 - 508.


Lacombe, D; Butler-Smith, A; Therasse, P; Fumoleau, P; Burtles, S; Calvert, H; Marsoni, S; (2003) Cancer drug development in Europe: A selection of new agents under development at the European Drug Development Network. CANCER INVEST , 21 (1) 137 - 147. 10.1081/CNV-120016408.

Lambert, S; Mason, SJ; Barber, LJ; Hartley, JA; Pearce, JA; Carr, AM; McHugh, PJ; (2003) Schizosaccharomyces pombe checkpoint response to DNA interstrand cross-links. MOL CELL BIOL , 23 (13) 4728 - 4737.

Lee, YC; Flora, R; McCafferty, JA; Gor, J; Tsaneva, IR; Perkins, SJ; (2003) A tetramer-octamer equilibrium in Mycobacterium leprae and Escherichia coli RuvA by analytical ultracentrifugation. J MOL BIOL , 333 (4) 677 - 682. 10.1016/j.jmb.2003.08.047.

Leonard, P; Sharp, T; Henderson, S; Hewitt, D; Pringle, J; Sandison, A; Goodship, A; (2003) Gene expression array profile of human osteosarcoma. BRIT J CANCER , 89 (12) 2284 - 2288. 10.1038/sj.bjc.6601389.

Leverrier, Y; Okkenhaug, K; Sawyer, C; Bilancio, A; Vanhaesebroeck, B; Ridley, AJ; (2003) Class I phosphoinositide 3-kinase p110 beta is required for apoptotic cell and Fc gamma receptor-mediated phagocytosis by macrophages. JOURNAL OF BIOLOGICAL CHEMISTRY , 278 (40) pp. 38437-38442. 10.1074/jbc.M306649200. Gold open access

Leverrier, Y; Okkenhaug, K; Sawyer, C; Bilancio, A; Vanhaesebroeck, B; Ridley, AJ; (2003) Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages. J Biol Chem , 278 (40) 38437 - 38442. 10.1074/jbc.M306649200. Gold open access

LoRusso, PM; Herbst, RS; Rischin, D; Ranson, M; Calvert, H; Raymond, E; Kieback, D; (2003) Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. CLIN CANCER RES , 9 (6) 2040 - 2048.


Maffucci, T; Brancaccio, A; Piccolo, E; Stein, RC; Falasca, M; (2003) Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO JOURNAL , 22 (16) pp. 4178-4189. 10.1093/emboj/cdg402.

Martin, F; Chowdhury, S; Neil, SJ; Chester, KA; Cosset, FL; Collins, MK; (2003) Targeted retroviral infection of tumor cells by receptor cooperation. J VIROL , 77 (4) 2753 - 2756. 10.1128/JVI.77.4.2753-2756.2003.

Martin, M; Spielmann, M; Namer, M; duBois, A; Unger, C; Dodwell, D; Vodvarka, P; (2003) Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines. ANN ONCOL , 14 (8) 1246 - 1252. 10.1093/annonc/mdg339.

Mayer, A; Tsiompanou, E; Flynn, AA; Pedley, RB; Dearling, J; Boden, R; Begent, RHJ; (2003) Higher dose and dose-rate in smaller tumors result in improved tumor control. CANCER INVEST , 21 (3) 382 - 388. 10.1081/CNV-120018229.

Meyer, T; McTiernan, A; Whelan, J; (2003) A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours. Sarcoma , 7 (1) pp. 13-17. 10.1080/1357714031000114192. Gold open access

Mungall, AJ; Palmer, SA; Sims, SK; Edwards, CA; Ashurst, JL; Wilming, L; Jones, MC; (2003) The DNA sequence and analysis of human chromosome 6. NATURE , 425 (6960) 805 - U1. 10.1038/nature02055.


Okkenhaug, K; Vanhaesebroeck, B; (2003) PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol , 3 (4) pp. 317-330. 10.1038/nri1056.

Okkenhaug, K; Vanhaesebroeck, B; (2003) PI3K-signalling in B- and T-cells: insights from gene-targeted mice. BIOCHEMICAL SOCIETY TRANSACTIONS , 31 pp. 270-274.


Plummer, R; Rees, C; Hughes, A; Beale, P; Highley, M; Trigo, J; Gokul, S; (2003) A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor. CLIN CANCER RES , 9 (4) 1313 - 1322.

Powles, T; Thirlwell, C; Nelson, M; Bower, M; (2003) Immune reconstitution inflammatory syndrome mimicking relapse of AIDS related lymphoma in patients with HIV 1 infection. LEUKEMIA LYMPHOMA , 44 (8) 1417 - 1419. 10.1080/1042819031000083280.


Reigner, B; Watanabe, T; Schuller, J; Lucraft, H; Sasaki, Y; Bridgewater, J; Saeki, T; (2003) Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 52 (3) pp. 193-201. 10.1007/s00280-003-0642-8.


Sarker, D; Thirlwell, C; Nelson, M; Gazzard, B; Bower, M; (2003) Leptomeningeal disease in AIDS-related non-Hodgkin's lymphoma. AIDS , 17 (6) 861 - 865. 10.1097/01.aids.0000050863.71999.f8.

Sawyer, C; Sturge, J; Bennett, DC; O'Hare, MJ; Allen, WE; Bain, J; Jones, GE; (2003) Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110 delta. CANCER RESEARCH , 63 (7) pp. 1667-1675.

Sayle, KL; Bentley, J; Boyle, FT; Calvert, AH; Cheng, YZ; Curtin, NJ; Endicott, JA; (2003) Structure-based design of 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinases 1 and 2. BIOORG MED CHEM LETT , 13 (18) 3079 - 3082. 10.1016/S0960-894X(03)00651-6.

Skalitzky, DJ; Marakovits, JT; Maegley, KA; Ekker, A; Yu, XH; Hostomsky, Z; Webber, SE; (2003) Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J MED CHEM , 46 (2) 210 - 213. 10.1021/jm0255769.

Smellie, M; Bose, DS; Thompson, AS; Jenkins, TC; Hartley, JA; Thurston, DE; (2003) Sequence-selective recognition of duplex DNA through covalent interstrand cross-linking: Kinetic and molecular modeling studies with pyrrolobenzodiazepine dimers. BIOCHEMISTRY-US , 42 (27) 8232 - 8239. 10.1021/bi034313t.

Stebbing, J; Wildfire, A; Portsmouth, S; Powles, T; Thirlwell, C; Hewitt, P; Nelson, M; (2003) Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. ANN ONCOL , 14 (11) 1660 - 1666. 10.1093/annonc/mdg461.

Strauss, SJ; Marples, M; Napier, MP; Meyer, T; Boxall, J; Rustin, GJ; (2003) A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma. Br J Cancer , 89 (10) pp. 1901-1905. 10.1038/sj.bjc.6601414.

Strauss, SJ; McTiernan, A; Driver, D; Hall-Craggs, M; Sandison, A; Cassoni, AM; Kilby, A; (2003) Single center experience of a new intensive induction therapy for Ewing's family of tumors: Feasibility, toxicity, and stem cell mobilization properties. Journal of Clinical Oncology , 21 (15) pp. 2974-2981. 10.1200/JCO.2003.04.106.

Strauss, SJ; McTiernan, A; Driver, D; Hall-Craggs, M; Sandison, A; Cassoni, AM; Kilby, A; (2003) Single center experience of a new intensive induction therapy for Ewing's family of tumors: Feasibility, toxicity, and stem cell mobilization properties. J CLIN ONCOL , 21 (15) 2974 - 2981. 10.1200/JCO.2003.04.106.

Sullivan, A; Uff, CR; Isacke, CM; Thorne, RF; (2003) PACE-1, a novel protein that interacts with the C-terminal domain of ezrin. Exp Cell Res , 284 (2) pp. 224-238.


Taylor, RM; Cheeseman, P; Preedy, V; Baker, AJ; Grimble, G; (2003) Can energy expenditure be predicted in critically ill children?. Pediatr Crit Care Med , 4 (2) pp. 176-180. 10.1097/01.PCC.0000059425.09149.D8.

Thirlwell, C; Brock, CS; (2003) Emergencies in oncology. CLIN MED , 3 (4) 306 - 310.

Thirlwell, C; Sarker, D; Stebbing, J; Bower, M; (2003) Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. CLIN LYMPHOMA , 4 (2) 86 - 92.

Tsotinis, A; Vlachou, M; Kiakos, K; Hartley, JA; Thurston, DE; (2003) Design and synthesis of two cytotoxic analogs of the novel pyrrolo[1 ',2 ': 1,2][1,4]diazepin [7,6-b]indol-5(6H)-one nucleus. CHEM LETT , 32 (6) 512 - 513. 10.1246/cl.2003.512.


Urbaniak, MD; Frost, LM; Bingham, JP; Kelland, LR; Hartley, JA; Woolfson, DN; Caddick, S; (2003) Chemical synthesis and cytotoxicity of dihydroxylated cyclopentenone analogues of neocarzinostatin chromophore. BIOORG MED CHEM LETT , 13 (12) 2025 - 2027. 10.1016/S0960-894X(03)00328-7.


Valovka, T; Verdier, F; Cramer, R; Zhyvoloup, A; Fenton, T; Rebholz, H; Wang, ML; (2003) Protein kinase C phosphorylates ribosomal protein S6 kinase beta II and regulates its subcellular localization. MOL CELL BIOL , 23 (3) 852 - 863. 10.1128/MCB.23.3.852-863.2003.


Wells, P; Aboagye, E; Gunn, RN; Osman, S; Boddy, AV; Taylor, GA; Rafi, I; (2003) 2-[C-11]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337. J NATL CANCER I , 95 (9) 675 - 682.

Westbury, CB; Harrington, KJ; Rhys-Evans, P; Archer, DJ; Searle, AE; Henk, JM; Black, CM; (2003) Raynaud's phenomenon after radical radiotherapy for tumours of the head and neck. POSTGRAD MED J , 79 (929) 176 - 177.

Whelan, J; (2003) Where should teenagers with cancer be treated? Eur J Cancer , 39 (18) pp. 2573-2578.


Zhyvoloup, A; Nemazanyy, I; Panasyuk, G; Valovka, T; Fenton, T; Rebholz, H; Wang, ML; (2003) Subcellular localization and regulation of coenzyme a synthase. J BIOL CHEM , 278 (50) 50316 - 50321. 10.1074/jbc.M307763200. Gold open access

This list was generated on Sun Nov 27 03:10:53 2016 GMT.